Clinical trial
Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease…
NCT00448071 · Wolfson Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00448071 |
|---|---|
| Title | Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients |
| Official title | A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients |
| Lead sponsor | Wolfson Medical Center, Other |
| Collaborators | Meditor Pharmaceuticals Ltd. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypotension, End Stage Renal Disease, Intra Dialytic Hypotension |
| Intervention type | Drug |
| Interventions | MTR107 |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 15, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: